Post by
BionicheStar on Jul 29, 2011 8:50am
ot) Awaiting 5 FDA approvals (Mcap 57 M)
GET IN NOW BEFORE THE STOCK GETS DISCOVERED !!!
This Unknown ULTRA LOW FLOAT Stock awaiting 5 FDA approvals and willrise to 7 by year end .I.TO has 15 Drugs in Pipeline many nearingANDA/NDA filing including a potential Blockbuster .
Market Cap 57 Mil / Cash 8.5 M / Burn-rate 4.5 M per Year = Enough Cash until Profitability which will happen in 2012
First FDA approval and PartnerShip which is imminent will push this low float rocket into double digits easily ..GLTA
Intellipharmaceutics (I.TO)
Market Cap: 57 M
Cash: 8.5 M
Price: 3.60 $
Shares Out: 15.9 Mil..(13 Mil Shares held by Insiders/Institutions)
Low Float : 2 M
Intellipharmaceutics now has five ANDAs awaiting FDA approval withreported sales for branded and generic versions of these products beingapproximately $8 billion in 2010. The Company develops both ANDA productcandidates and new drugs through the New Drug Application (NDA)505(b)(2) regulatory pathway.
"The filing of a generic version of Seroquel XR® is one of the Company'sperformance milestones for 2011 and another important addition to ourproduct portfolio filed for approval with the FDA, which includesgenerics of Focalin XR®, Effexor XR®, Protonix® DR and Glucophage® XR,"commented Dr. Isa Odidi, CEO of Intellipharmaceutics. "These filings notonly provide further validation of our Hypermatrix™ technology, theyclearly demonstrate the flexibility of our technology to efficiently andeffectively match a number of drug delivery profiles."